This Boehringer Ingelheim Idiopathic Pulmonary Fibrosis video explains high-resolution computerized tomography (HRCT) scans. While there is no known cause for idiopathic pulmonary fibrosis, there are some aspects which could be to blame. Find out more. This animated film explains why patients with pulmonary fibrosis would need an HRCT…
Patients with idiopathic pulmonary fibrosis (IPF) have a high risk of developing other health conditions, according to results of a study presented at the annual meeting of the American College of Chest Physicians (CHEST 2016), held in Los Angeles Oct. 22-26. The results were presented under the title “Longitudinal…
Sometimes it is hard to keep going when you have pulmonary fibrosis The basics of living life and traveling are now such a challenge for me … like breathing, walking, being tired, having to bring oxygen and needing help. I recently attended a Writer’s…
The effectiveness of long-term treatment with the anti fibrotic drug Esbriet (pirfenidone) for more than 3 years does not depend on the forced vital capacity (FVC) at baseline in patients with idiopathic pulmonary fibrosis (IPF), according to a clinical trial called RECAP (NCT00662038).
According to PulmonaryFibrosis.org, there are several types of treatment options to help you with your pulmonary fibrosis. In this article, we’re focusing on bringing you non-pharmacological pulmonary fibrosis treatments. 1. Do not smoke! If you’ve been diagnosed with pulmonary fibrosis or any other lung disease, smoking is…
Esbriet (pirfenidone) can be used as a long-term therapy in idiopathic pulmonary fibrosis (IPF) patients with more severe loss of lung function, according to results presented at the American College of Chest Physicians (CHEST 2016), held in Los Angeles from Oct. 22–26. The findings were described in the oral presentation, “…
In this University of Exeter video, Dr. Chris Scotton talks about his research in idiopathic pulmonary fibrosis in order to better understand the development of the disease, and to try to develop new model systems for drug testing. Discover why pulmonary fibrosis is so…
Results from two Phase 3 studies, known as the INPULSIS trials, further confirmed the efficacy of Ofev (nintedanib) to treat idiopathic pulmonary fibrosis (IPF) regardless of disease severity. The results, from post-hoc pooled analyses of the trials, were recently presented at the CHEST 2016 Annual Meeting, running in Los Angeles through Wednesday, Oct. 26.
In this film produced and shared by Elisabeth Leveque-Mumford in July 2011, we meet Hélène Campbell a young woman who had just recently been diagnosed with advanced idiopathic pulmonary fibrosis (IPF). Discover six less-common symptoms of idiopathic pulmonary fibrosis here. Hélène talks about how IPF has impacted her life,…
I recently had a victory in a fight for oxygen, and wanted to share what I learned through the process. I had to fight for oxygen … pretty basic need, right? Like many of you, I’m on supplemental oxygen 24/7. It’s been two years, and it has been a fight…
Get regular updates to your inbox.
